PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-Apr-2026 Robbins LLP Urges Investors Who Lost Money Investing in Medpace Holdings Inc. to Contact the Firm for Information About Leading the Class Action Against MEDP Businesswire
20-Apr-2026 Robbins LLP Encourages SLNO Stockholders to Contact the Firm for Information About the Class Action Against Soleno Therapeutics, Inc. Businesswire
20-Apr-2026 Robbins LLP Encourages BSX Stockholders to Contact the Firm for Information About the Class Action Against Boston Scientific Businesswire
20-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
20-Apr-2026 Minutes of IMPLANET’s Annual General Meeting Held on April 17, 2026 Businesswire
20-Apr-2026 Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions Integrated DNA Technologies
20-Apr-2026 Claritas Rx Introduces Omnichannel CRM to Transform Patient Services and Speed Access to Specialty Therapies Businesswire
20-Apr-2026 LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc. ACCESS Newswire
20-Apr-2026 Phenom is the Highest-Designated Leader in Everest Group’s Skills Intelligence Platforms PEAK Matrix® Assessment 2026 Businesswire
20-Apr-2026 Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders ACCESS Newswire
20-Apr-2026 ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint ACCESS Newswire
20-Apr-2026 AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call Businesswire
20-Apr-2026 Allurion Treats First Commercial Patients in the United States, Marking Major Milestone Businesswire
20-Apr-2026 Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer Businesswire
20-Apr-2026 Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research Businesswire
20-Apr-2026 Maxell Establishes Corporate Byline “Micro batteries. Maximum impact.” Businesswire
20-Apr-2026 Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School Businesswire
20-Apr-2026 Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy Businesswire
20-Apr-2026 Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors Businesswire
20-Apr-2026 Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026 Businesswire